Prescription Drug Marketing Act (PDMA) Regulations - MedProID

History Of The PDMA

The Prescription Drug Marketing Act of 1987 (PDMA) was passed to regulate and prevent improper distribution of pharmaceutical product samples. The rules and procedures set forth by the FDA effective December 4, 2000 concludes, “Where a practitioner has a state license number, that number must be used for verification purposes” {21 CFR Parts 203.30(a)(2)}. Complicating these stringent requirements, each state and its individual boards independently maintain practitioner-licensing information. The need to obtain and consolidate state license information into a uniform and accessible database requires today’s best information technologies. MedProID® was implemented to aid pharmaceutical companies in achieving PDMA compliance. PDMA license validation is fully supported across the entire MedProID® suite of solutions. This includes support in WebID®, BulkID and WebServicesID®, AffiliationID®, BestInfoID®, Call Center, MobileID®, Practitioner ProximityID®, Sampleability Updates®, SanctionID® and Shippability®.

To learn more about federal PDMA regulations please visit the FDA website:

MedPro has been a PDMA Alliance member for over ten years, 2001 - Present

PDMA Alliance

The PDMA Alliance Inc. is dedicated to improving the understanding of the Prescription Drug Marketing Act (PDMA). Its members are pharmaceutical executives who are directly or indirectly involved or impacted by sample accountability and related fraud and abuse issues. Working closely with the U.S. Food and Drug Administration (FDA) and providing current information regarding federal and state legislation are among the many significant ways that The Alliance supports its members throughout the year.

Access to the most updated HCP and HCO licensing data is just a few clicks away

Request a Demo